# Kronox Lab Sciences (NSE: KRONOX) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/KRONOX · Pivot · prices to 21 Oct 2026

Kronox Lab Sciences (NSE: KRONOX) closed at ₹190.15 on 21 Oct 2026. With a market capitalisation of ₹737 Cr, it ranks 1617th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.

At its last close the stock traded at 26.7× trailing earnings, against a return on equity of 28.3% in FY25. Over the past year the share price has risen 31.2%. Its 52-week range is ₹96.00 (30 Mar 2026) to ₹227.74 (29 Sep 2026); the last close is 16.5% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹26 Cr (0.0% year on year) and net profit ₹8 Cr (+26.6%), on a standalone basis. Promoters held 74.21% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹190.15 |
| Market cap | ₹737 Cr |
| P/E (trailing) | 26.7 |
| ROE | 28.3% (FY25) |
| ROCE | 38.0% (FY25) |
| Debt to equity | 0 |
| 52-week high | ₹227.74 (29 Sep 2026) |
| 52-week low | ₹96.00 (30 Mar 2026) |
| 1-year return | +31.2% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹26 Cr | 0.0% | ₹8 Cr | +26.6% | ₹2.18 |
| Q3 FY26 | ₹25 Cr | +5.2% | ₹7 Cr | +0.9% | ₹1.79 |
| Q2 FY26 | ₹26 Cr | +2.7% | ₹7 Cr | +3.2% | ₹1.82 |
| Q1 FY26 | ₹24 Cr | −3.6% | ₹6 Cr | +2.1% | ₹1.70 |
| Q4 FY25 | ₹26 Cr | +17.8% | ₹6 Cr | +7.5% | ₹1.72 |
| Q3 FY25 | ₹24 Cr | +15.9% | ₹7 Cr | +34.9% | ₹1.77 |
| Q2 FY25 | ₹25 Cr | +18.3% | ₹6 Cr | +52.2% | ₹1.76 |
| Q1 FY25 | ₹25 Cr | −2.9% | ₹6 Cr | −3.6% | ₹1.67 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹100 Cr | ₹25 Cr |
| FY24 | ₹90 Cr | ₹21 Cr |
| FY23 | ₹96 Cr | ₹17 Cr |
| FY22 | ₹82 Cr | ₹14 Cr |
| FY21 | ₹62 Cr | ₹10 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 74.21%
- Foreign institutions: 0.04%
- Domestic institutions: 2.07%
- Non-institutions: 23.67%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Transpek Industry](https://app.pivotnow.in/stock/TRANSPEK) | ₹1,397.90 | ₹781 Cr | 17.1 | — |
| [Kanoria Chemicals & Industries](https://app.pivotnow.in/stock/KANORICHEM) | ₹178.32 | ₹779 Cr | 19.5 | — |
| [Gem Aromatics](https://app.pivotnow.in/stock/GEMAROMA) | ₹147.50 | ₹770 Cr | — | — |
| [ZUARI INDUSTRIES](https://app.pivotnow.in/stock/ZUARIIND) | ₹258.10 | ₹769 Cr | 7.1 | — |
| [Sadhana Nitrochem](https://app.pivotnow.in/stock/SADHNANIQ) | ₹2.59 | ₹768 Cr | — | — |
| [Shalimar Paints](https://app.pivotnow.in/stock/SHALPAINTS) | ₹80.55 | ₹674 Cr | — | — |

## Questions and answers

### What is the share price of Kronox Lab Sciences today?

Kronox Lab Sciences (NSE: KRONOX) last closed at ₹190.15 on 21 Oct 2026. Its 52-week high is ₹227.74 and its 52-week low is ₹96.00.

### What is the market cap of Kronox Lab Sciences?

Kronox Lab Sciences' market capitalisation is ₹737 Cr (₹737 Cr) at the 19 Oct 2026 close, ranking 1617th among the NSE companies Pivot tracks.

### What is the P/E ratio of Kronox Lab Sciences?

Kronox Lab Sciences trades at a trailing P/E of 26.7. The median P/E of the 3 closest Chemicals peers by market cap is 17.1.

### What is the ROE and ROCE of Kronox Lab Sciences?

Return on equity was 28.3% in FY25 and return on capital employed was 38.0% in FY25 (standalone figures).

### Is Kronox Lab Sciences a debt-free company?

Kronox Lab Sciences is close to debt-free: its debt-to-equity ratio was 0 in FY25.

### What were Kronox Lab Sciences' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Kronox Lab Sciences reported revenue of ₹26 Cr, 0.0% year on year, and net profit of ₹8 Cr, +26.6% year on year.

### How has Kronox Lab Sciences stock performed over the last year?

Kronox Lab Sciences' share price has risen 31.2% over the past year, +29.0% over three months and +14.3% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Kronox Lab Sciences?

As of 30 Jun 2026: promoters 74.21%, foreign institutions 0.04%, domestic institutions 2.07%, non-institutions 23.67%.

### Who are Kronox Lab Sciences' competitors?

The listed Chemicals companies closest to Kronox Lab Sciences by market cap are Transpek Industry, Kanoria Chemicals & Industries, Gem Aromatics, ZUARI INDUSTRIES, Sadhana Nitrochem and Shalimar Paints.

### Is Kronox Lab Sciences a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Kronox Lab Sciences' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KRONOX against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.